Cadrenal Therapeutics, Inc. · NASDAQ:CVKD
Cadrenal Therapeutics, Inc. shareholders
As of Sep 30, 2026, 22 institutions reported holding Cadrenal Therapeutics, Inc., 4.4% of its shares. Largest: Hrt Financial LP, Vanguard and Courier Capital LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cadrenal Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Hrt Financial LP | 35,375 | 0.86% | +6,320 | Nov 13, 2026 |
| Vanguard | 25,170 | 0.61% | −33,278 | Nov 13, 2026 |
| Courier Capital LLC | 19,837 | 0.48% | new | Oct 19, 2026 |
| Vectors Research Management, LLC | 19,837 | 0.48% | new | Nov 9, 2026 |
| Geode Capital | 18,958 | 0.46% | −66 | Nov 6, 2026 |
| Jane Street | 13,721 | 0.33% | new | Nov 12, 2026 |
| Squarepoint Ops LLC | 12,363 | 0.30% | new | Nov 9, 2026 |
| XTX Topco Ltd | 10,103 | 0.25% | new | Nov 16, 2026 |
| Nuveen | 7,240 | 0.18% | new | Nov 10, 2026 |
| UBS | 5,861 | 0.14% | +4,749 | Nov 10, 2026 |